Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CAEP NYSE:DNI NASDAQ:OACC NASDAQ:RANG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCAEPCantor Equity Partners III$10.77-1.4%$0.00$10.30▼$11.09$333.93MN/A1.05 million shs226,935 shsDNIDividend and Income Fund$9.79$9.76$6.55▼$13.97$121.89M1.3363,824 shs88,009 shsOACCOaktree Acquisition Corp. III Life Sciences$10.43-0.1%$10.48$9.95▼$10.85$234.12MN/A24,498 shs16,410 shsRANGRange Capital Acquisition$10.26-0.4%$10.22$9.91▼$10.64$144.20MN/A21,252 shs877 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCAEPCantor Equity Partners III-0.27%+4.70%+1,091,999,900.00%+1,091,999,900.00%+1,091,999,900.00%DNIDividend and Income Fund0.00%0.00%0.00%0.00%0.00%OACCOaktree Acquisition Corp. III Life Sciences+0.19%+0.38%-1.42%+3.26%+1,043,999,900.00%RANGRange Capital Acquisition+0.39%+0.49%+0.98%+2.59%+1,029,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCAEPCantor Equity Partners IIIN/AN/AN/AN/AN/AN/AN/AN/ADNIDividend and Income FundN/AN/AN/AN/AN/AN/AN/AN/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AN/AN/AN/ARANGRange Capital AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCAEPCantor Equity Partners III 0.00N/AN/AN/ADNIDividend and Income Fund 0.00N/AN/AN/AOACCOaktree Acquisition Corp. III Life Sciences 0.00N/AN/AN/ARANGRange Capital Acquisition 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCAEPCantor Equity Partners IIIN/AN/AN/AN/AN/AN/ADNIDividend and Income FundN/AN/AN/AN/AN/AN/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AN/ARANGRange Capital AcquisitionN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCAEPCantor Equity Partners IIIN/AN/A0.00∞N/AN/AN/AN/AN/ADNIDividend and Income FundN/AN/A0.00∞N/AN/AN/AN/AN/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/A0.00∞N/AN/AN/AN/AN/ARANGRange Capital AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCAEPCantor Equity Partners IIIN/AN/AN/AN/AN/ADNIDividend and Income Fund$0.959.70%N/AN/AN/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/ARANGRange Capital AcquisitionN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCAEPCantor Equity Partners IIIN/ADNIDividend and Income Fund42.47%OACCOaktree Acquisition Corp. III Life SciencesN/ARANGRange Capital AcquisitionN/AInsider OwnershipCompanyInsider OwnershipCAEPCantor Equity Partners IIIN/ADNIDividend and Income Fund1.00%OACCOaktree Acquisition Corp. III Life SciencesN/ARANGRange Capital AcquisitionN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCAEPCantor Equity Partners III230.58 millionN/AN/ADNIDividend and Income FundN/A12.45 millionN/ANot OptionableOACCOaktree Acquisition Corp. III Life SciencesN/A22.42 millionN/AN/ARANGRange Capital AcquisitionN/A14.00 millionN/AN/ADNI, CAEP, OACC, and RANG HeadlinesRecent News About These CompaniesDakota Wealth Management Buys New Stake in Range Capital Acquisition Corp. (NASDAQ:RANG)July 18 at 5:29 AM | marketbeat.comWealthspring Capital LLC Buys Shares of 155,080 Range Capital Acquisition Corp. (NASDAQ:RANG)July 15 at 9:40 AM | marketbeat.comSchechter Investment Advisors LLC Takes Position in Range Capital Acquisition Corp. (NASDAQ:RANG)July 13, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDNI, CAEP, OACC, and RANG Company DescriptionsCantor Equity Partners III NASDAQ:CAEP$10.77 -0.15 (-1.37%) As of 04:00 PM EasternWe are a blank check company incorporated on November 11, 2020 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any discussions, directly or indirectly, with any business combination target regarding an initial business combination with our company. Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region, although we expect to focus on a target in an industry where we believe our management team’s and our affiliates’ expertise will provide us with a competitive advantage, including the financial services, digital assets, healthcare, real estate services, technology and software industries. Further, our efforts to identify a prospective target business will not be limited to any characteristics, although we expect to favor potential target companies with certain characteristics which include, but are not limited to, positive long term growth prospects, competitive advantages, consolidation opportunities, recurring revenue or the potential for recurring revenue, opportunities for operational improvement and attractive margins or the potential for attractive margins. Our executive offices are located New York, New York.Dividend and Income Fund NYSE:DNIOaktree Acquisition Corp. III Life Sciences NASDAQ:OACC$10.43 -0.01 (-0.10%) As of 03:32 PM EasternOaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.Range Capital Acquisition NASDAQ:RANG$10.26 -0.04 (-0.39%) As of 12:00 PM EasternRange Capital Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on July 24, 2024 and is headquartered in New York, NY. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era How Goldman Sachs Earnings Help You Strategize Your Portfolio Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.